MOLECULARMD CORP. — Form D/A

MOLECULARMD CORP. of PORTLAND, OR, a company, filed a Form D amendment with the SEC on 2012-04-05. The offering totals $9.0M, of which $8.0M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (21)

NameRoleLocation
Richard D BrandewieDirectorWest Palm Beach, FL
Teri D SwiftExecutive OfficerWest Palm Beach, FL
Stephane D WongExecutive OfficerWest Palm Beach, FL
MATTHEW C RICEDirectorTAMPA, FL
DREW A GRAHAMDirectorTAMPA, FL
Ryan G DunlapExecutive OfficerVancouver, WA
Chad G GalderisiExecutive OfficerPortland, OR
Sheridan D SnyderDirectorPortland, OR
Sheridan D SnyderExecutive OfficerPortland, OR
Sheridan G SnyderDirectorPortland, OR
Sheridan G SnyderExecutive OfficerPortland, OR
Matthew G RiceDirectorPortland, OR
Frederick G EibelExecutive OfficerPortland, OR
Peter G MaagDirectorPortland, OR
Cindy G SpittleExecutive OfficerPortland, OR
Drew G GrahamDirectorPortland, OR
Ryan D DunlapExecutive OfficerPortland, OR
Chad D GalderisiDirectorWest Palm Beach, FL
Peter C MaagDirectorWest Palm Beach, FL
Fritz C EibelDirectorWest Palm Beach, FL
Cheryl D CalhounExecutive OfficerWest Palm Beach, FL

Other filings by this issuer (4)

FiledFormOfferingSold
2017-02-10D$2.1M$2.1M
2016-07-18D$2.0M$500K
2013-05-20D$2.5M$2.5M
2012-02-15D$8.0M$8.0M

More